Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management ... You can sense this in other Kellogg graduates when you meet them out in the world.” President of Takeda Pharmaceutical ...

Global pharmaceutical giant Takeda Group has appointed Julie Kim, the current head of its U.S. subsidiary, as the next chief executive officer (CEO) of the group. Takeda is the largest corporation ...

We apologize, but this video has failed to load. “The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber ...

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker. OSAKA, Japan & CAMBRIDGE, Mass., January 30, 2025--Takeda ...

Rio Takeda of Japan shot a 3-under 69 to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s ...

Takeda(TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor t ...